Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
❤️ BS EN ISO 5840 is the British Standards Institution (BSI) implementation of the European Standard EN ISO 5840, corresponding to the international ISO 5840 series on cardiovascular implants, with the subject “cardiac valve prostheses”. The series has several parts; this batch covers two: Part 1 “general requirements” and Part 3 “heart valve substitutes implanted by transcatheter techniques”. In the UK it is prepared under Technical Committee CH/150/2 (Cardiovascular implants), and falls under ICS 11.040.40 (Implants for surgery). The series provides a unified basis for the safety, performance and clinical evaluation of artificial heart valves, and is a major technical support for market conformity of valve products under the Medical Device Regulation (MDR).
Cardiac valve prostheses replace native valves diseased by stenosis or regurgitation (aortic, mitral, etc.). The BS EN ISO 5840 series specifies requirements for design, materials, in-vitro testing, animal testing and clinical evaluation of cardiac valve prostheses, covering both surgical and transcatheter implant valves. Part 1 gives general requirements (terminology, classification, risk management, testing general principles), while Part 3 gives specific safety and performance requirements for valves implanted by transcatheter techniques (TAVI/TAVR, TMVR and other minimally invasive procedures).
| Part | Year | Subject | Key Content | Applicable Objects |
|---|---|---|---|---|
| BS EN ISO 5840-1 | 2015 | Cardiac valve prostheses — general requirements | Terminology, classification, risk management, materials, general test principles | All cardiac valve prostheses |
| BS EN ISO 5840-3 | 2013 | Heart valve substitutes — transcatheter implantation | Delivery/release system, implantation performance, paravalvular leakage, clinical evaluation | TAVI/TAVR, TMVR and other transcatheter valves |
Part 1 (2015) serves as the general top-level document providing a common basis for other parts; Part 3 (2013) gives specific requirements for transcatheter techniques, a rapidly developing minimally invasive procedure. Both parts were prepared under a mandate supporting EU Directive(s), including Annex ZA links to EU legislation.
General requirements cover: valve classification (mechanical, tissue, transcatheter, etc.), design input (haemodynamic targets, valve size, materials), risk management (risk analysis per ISO 14971), in-vitro performance testing (transvalvular pressure gradient, effective orifice area, regurgitation fraction, valve opening/closing dynamics), durability (accelerated wear and pulsatile-flow fatigue), and animal/clinical evaluation.
On top of the general requirements, Part 3 adds for transcatheter valves: manoeuvrability of the delivery system and catheter, compression/re-expansion performance of the valve in the delivery state, precise release and positioning, anchoring and sealing (prevention of paravalvular leakage), effects on perivalvular tissue and the conduction system (e.g. risk of atrioventricular block), and post-implant haemodynamic and long-term durability evaluation.
Valve materials (metallic frames, polymers, biological tissue leaflets) must meet biocompatibility (per relevant ISO 10993 requirements), corrosion resistance, fatigue resistance and long-term stability; biological tissue should be appropriately processed and fixed to ensure structural integrity and anti-calcification performance.
The standard emphasises the rigour of clinical evaluation and post-market surveillance, requiring haemodynamic, complication (thrombosis, embolism, bleeding, structural deterioration, paravalvular leakage, etc.) and patient follow-up data to be collected per clinical protocols, providing evidence for continuous improvement and regulatory decisions.